{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T22:01:42Z","timestamp":1790028102310,"version":"4.0.1"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T00:00:00Z","timestamp":1654646400000},"content-version":"vor","delay-in-days":1953,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000902","name":"Pediatric Cancer Research Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000902","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100006058","name":"St. Baldrick's Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100006058","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Marisa Fund"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","exphem.org","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.exphem.2016.10.003","type":"journal-article","created":{"date-parts":[[2016,10,19]],"date-time":"2016-10-19T14:38:49Z","timestamp":1476887929000},"page":"38-47","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Genetically re-engineered K562\u00a0cells significantly expand and functionally activate cord blood natural killer cells: Potential for adoptive cellular immunotherapy"],"prefix":"10.1016","volume":"46","author":[{"given":"Janet","family":"Ayello","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Hochberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allyson","family":"Flower","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaya","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laxmi V.","family":"Baxi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Quish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmella","family":"van de Ven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell S.","family":"Cairo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exphem.2016.10.003_bib1","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.beha.2008.07.008","article-title":"Use of natural killer cells as immunotherapy for leukaemia","volume":"21","author":"Grzywacz","year":"2008","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1016\/j.exphem.2016.10.003_bib2","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1016\/S0140-6736(00)03231-1","article-title":"Natural cytotoxic activity of peripheral-blood lymphocytes and cancer incidence: an 11-year follow-up study of a general population","volume":"356","author":"Imai","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.exphem.2016.10.003_bib3","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/j.1537-2995.2006.01145.x","article-title":"Good manufacturing practices production of natural killer cells for immunotherapy: a six-year single-institution experience","volume":"47","author":"McKenna","year":"2007","journal-title":"Transfusion"},{"key":"10.1016\/j.exphem.2016.10.003_bib4","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1084\/jem.20031981","article-title":"Innate immune surveillance of spontaneous B cell lymphomas by natural killer cells and gammadelta T cells","volume":"199","author":"Street","year":"2004","journal-title":"J Exp Med"},{"key":"10.1016\/j.exphem.2016.10.003_bib5","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.3324\/haematol.13033","article-title":"The relationship between circulating natural killer cells after reduced intensity conditioning hematopoietic stem cell transplantation and relapse-free survival and graft-versus-host disease","volume":"93","author":"Dunbar","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.exphem.2016.10.003_bib6","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1126\/science.1068440","article-title":"Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants","volume":"295","author":"Ruggeri","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.exphem.2016.10.003_bib7","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/pbc.21158","article-title":"Human natural killer cells in health and disease","volume":"49","author":"Shereck","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.exphem.2016.10.003_bib8","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nri3174","article-title":"Targeting natural killer cells and natural killer T cells in cancer","volume":"12","author":"Vivier","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.exphem.2016.10.003_bib9","doi-asserted-by":"crossref","first-page":"4010","DOI":"10.1158\/0008-5472.CAN-08-3712","article-title":"Expansion of highly cytotoxic human natural killer cells for cancer cell therapy","volume":"69","author":"Fujisaki","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.exphem.2016.10.003_bib10","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1182\/blood-2004-12-4797","article-title":"Genetic modification of primary natural killer cells overcomes inhibitory signals and induces specific killing of leukemic cells","volume":"106","author":"Imai","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2016.10.003_bib11","doi-asserted-by":"crossref","first-page":"4665","DOI":"10.1182\/blood.V90.12.4665","article-title":"Placental and\/or umbilical cord blood: an alternative source of hematopoietic stem cells for transplantation","volume":"90","author":"Cairo","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2016.10.003_bib12","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1365-2141.2011.08822.x","article-title":"A comparison of immune reconstitution and graft-versus-host disease following myeloablative conditioning versus reduced toxicity conditioning and umbilical cord blood transplantation in paediatric recipients","volume":"155","author":"Geyer","year":"2011","journal-title":"Br J Haematol"},{"key":"10.1016\/j.exphem.2016.10.003_bib13","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1365-2141.2012.09048.x","article-title":"T cell depletion utilizing CD34(+) stem cell selection and CD3(+) addback from unrelated adult donors in paediatric allogeneic stem cell transplantation recipients","volume":"157","author":"Geyer","year":"2012","journal-title":"Br J Haematol"},{"key":"10.1016\/j.exphem.2016.10.003_bib14","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1056\/NEJM199607183350303","article-title":"Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients","volume":"335","author":"Kurtzberg","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2016.10.003_bib15","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.exphem.2011.01.002","article-title":"Cord blood transplantation and stem cell regenerative potential","volume":"39","author":"Liao","year":"2011","journal-title":"Exp Hematol"},{"key":"10.1016\/j.exphem.2016.10.003_bib16","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.humimm.2005.01.010","article-title":"Cord blood immunology and stem cell transplantation","volume":"66","author":"Bradley","year":"2005","journal-title":"Hum Immunol"},{"key":"10.1016\/j.exphem.2016.10.003_bib17","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/S0301-472X(00)00617-2","article-title":"Ex\u00a0vivo expansion of CD56+ cytotoxic cells from human umbilical cord blood","volume":"29","author":"Condiotti","year":"2001","journal-title":"Exp Hematol"},{"key":"10.1016\/j.exphem.2016.10.003_bib18","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1053\/bbmt.2002.v8.pm12171483","article-title":"Transplantation of ex\u00a0vivo expanded cord blood","volume":"8","author":"Shpall","year":"2002","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.exphem.2016.10.003_bib19","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1053\/j.seminhematol.2009.10.009","article-title":"Unrelated umbilical cord blood transplantation and immune reconstitution","volume":"47","author":"Szabolcs","year":"2010","journal-title":"Semin Hematol"},{"key":"10.1016\/j.exphem.2016.10.003_bib20","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1038\/leu.2011.345","article-title":"Expansion of NK cells from cord blood with antileukemic activity using GMP-compliant substances without feeder cells","volume":"26","author":"Tanaka","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2016.10.003_bib21","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.exphem.2009.07.009","article-title":"Characterization of natural killer and natural killer-like T cells derived from ex\u00a0vivo expanded and activated cord blood mononuclear cells: implications for adoptive cellular immunotherapy","volume":"37","author":"Ayello","year":"2009","journal-title":"Exp Hematol"},{"key":"10.1016\/j.exphem.2016.10.003_bib22","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1080\/10826080701690714","article-title":"Phenotypic and functional heterogeneity of natural killer cells from umbilical cord blood mononuclear cells","volume":"37","author":"Fan","year":"2008","journal-title":"Immunol Invest"},{"key":"10.1016\/j.exphem.2016.10.003_bib23","doi-asserted-by":"crossref","first-page":"264","DOI":"10.3389\/fimmu.2015.00264","article-title":"Natural killer cell immunotherapy: from bench to bedside","volume":"6","author":"Domogala","year":"2015","journal-title":"Front Immunol"},{"key":"10.1016\/j.exphem.2016.10.003_bib24","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.bbmt.2006.01.009","article-title":"Characterization of cord blood natural killer and lymphokine activated killer lymphocytes following ex\u00a0vivo cellular engineering","volume":"12","author":"Ayello","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.exphem.2016.10.003_bib25","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1089\/scd.1.1998.7.521","article-title":"Cord Blood. Transplantation Study (COBLT): cord blood bank standard operating procedures","volume":"7","author":"Fraser","year":"1998","journal-title":"J Hematother"},{"key":"10.1016\/j.exphem.2016.10.003_bib26","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1158\/2326-6066.CIR-14-0114","article-title":"Targeting CD20+ aggressive B-cell non-Hodgkin lymphoma by Anti-CD20 CAR mRNA-modified expanded natural killer cells in\u00a0vitro and in NSG mice","volume":"3","author":"Chu","year":"2015","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.exphem.2016.10.003_bib27","doi-asserted-by":"crossref","first-page":"14342","DOI":"10.1073\/pnas.0804105105","article-title":"Visualizing fewer than 10 mouse T cells with an enhanced firefly luciferase in immunocompetent mouse models of cancer","volume":"105","author":"Rabinovich","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.exphem.2016.10.003_bib28","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1126\/science.1151124","article-title":"Correlation of the highest-energy cosmic rays with nearby extragalactic objects","volume":"318","author":"Pierre Auger","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.exphem.2016.10.003_bib29","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1182\/blood-2007-06-092817","article-title":"In\u00a0vivo trafficking and survival of cytokine-induced killer cells resulting in minimal GVHD with retention of antitumor activity","volume":"112","author":"Nishimura","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2016.10.003_bib30","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/BF00300234","article-title":"Determination of subcutaneous tumor size in athymic (nude) mice","volume":"24","author":"Tomayko","year":"1989","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.exphem.2016.10.003_bib31","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s11596-010-0465-x","article-title":"Quantitative analysis of cell tracing by in\u00a0vivo imaging system","volume":"30","author":"Zheng","year":"2010","journal-title":"J Huazhong Univ Sci Technolog Med Sci"},{"key":"10.1016\/j.exphem.2016.10.003_bib32","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1097\/JSM.0b013e31815889e2","article-title":"Hypothenar hammer syndrome in two collegiate athletes: immediate versus delayed surgical treatment","volume":"17","author":"Hendrickson","year":"2007","journal-title":"Clin J Sport Med"},{"key":"10.1016\/j.exphem.2016.10.003_bib33","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S1471-4906(01)02060-9","article-title":"The biology of human natural killer-cell subsets","volume":"22","author":"Cooper","year":"2001","journal-title":"Trends Immunol"},{"key":"10.1016\/j.exphem.2016.10.003_bib34","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1203\/01.PDR.0000156501.55431.20","article-title":"Characterization of cord blood natural killer cells: implications for transplantation and neonatal infections","volume":"57","author":"Dalle","year":"2005","journal-title":"Pediatr Res"},{"key":"10.1016\/j.exphem.2016.10.003_bib35","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.blre.2005.10.001","article-title":"Human natural killer cell development and biology","volume":"20","author":"Farag","year":"2006","journal-title":"Blood Rev"},{"key":"10.1016\/j.exphem.2016.10.003_bib36","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/ni0102-6","article-title":"What is a natural killer cell?","volume":"3","author":"Moretta","year":"2002","journal-title":"Nat Immunol"},{"key":"10.1016\/j.exphem.2016.10.003_bib37","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jim.2004.08.008","article-title":"CD107a as a functional marker for the identification of natural killer cell activity","volume":"294","author":"Alter","year":"2004","journal-title":"J Immunol Methods"},{"issue":"Suppl A","key":"10.1016\/j.exphem.2016.10.003_bib38","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1053\/ejpn.2000.0428","article-title":"Lysosomal membrane proteins","volume":"5","author":"Winchester","year":"2001","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.exphem.2016.10.003_bib39","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0022-1759(03)00265-5","article-title":"Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation","volume":"281","author":"Betts","year":"2003","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.exphem.2016.10.003_bib40","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1084\/jem.175.4.1055","article-title":"Ontogeny of human natural killer (NK) cells: fetal NK cells mediate cytolytic function and express cytoplasmic CD3 epsilon,delta proteins","volume":"175","author":"Phillips","year":"1992","journal-title":"J Exp Med"},{"key":"10.1016\/j.exphem.2016.10.003_bib41","first-page":"89","article-title":"Expansion and activation of natural killer cells for cancer immunotherapy","volume":"29","author":"Cho","year":"2009","journal-title":"Korean J Lab Med"},{"key":"10.1016\/j.exphem.2016.10.003_bib42","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1399-0039.2011.01796.x","article-title":"Natural killer cell engineering for cellular therapy of cancer","volume":"78","author":"Shook","year":"2011","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.exphem.2016.10.003_bib43","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1158\/0008-5472.CAN-12-3558","article-title":"A chimeric receptor with Nkg2d specificity enhances natural killer cell activation and killing of tumor cells","volume":"73","author":"Chang","year":"2013","journal-title":"Cancer Res"},{"key":"10.1016\/j.exphem.2016.10.003_bib44","doi-asserted-by":"crossref","first-page":"e76781","DOI":"10.1371\/journal.pone.0076781","article-title":"Antigen presenting cell-mediated expansion of human umbilical cord blood yields log-scale expansion of natural killer cells with anti-myeloma activity","volume":"8","author":"Shah","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.exphem.2016.10.003_bib45","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0198-8859(98)00126-8","article-title":"Analysis of the cytokine production by cord and adult blood","volume":"60","author":"Cohen","year":"1999","journal-title":"Hum Immunol"},{"key":"10.1016\/j.exphem.2016.10.003_bib46","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1089\/jir.1995.15.527","article-title":"Cord blood natural killer cells are functionally and phenotypically immature but readily respond to interleukin-2 and interleukin-12","volume":"15","author":"Gaddy","year":"1995","journal-title":"J Interferon Cytokine Res"},{"key":"10.1016\/j.exphem.2016.10.003_bib47","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/j.jcyt.2015.07.020","article-title":"A novel method to expand large numbers of CD56(+) natural killer cells from a minute fraction of selectively accessed cryopreserved cord blood for immunotherapy after transplantation","volume":"17","author":"Vasu","year":"2015","journal-title":"Cytotherapy"},{"key":"10.1016\/j.exphem.2016.10.003_bib48","doi-asserted-by":"crossref","first-page":"e20740","DOI":"10.1371\/journal.pone.0020740","article-title":"Clinical-grade generation of active NK cells from cord blood hematopoietic progenitor cells for immunotherapy using a closed-system culture process","volume":"6","author":"Spanholtz","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.exphem.2016.10.003_bib49","doi-asserted-by":"crossref","first-page":"e64384","DOI":"10.1371\/journal.pone.0064384","article-title":"Natural killer cells generated from cord blood hematopoietic progenitor cells efficiently target bone marrow-residing human leukemia cells in NOD\/SCID\/IL2Rg(null) mice","volume":"8","author":"Cany","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.exphem.2016.10.003_bib50","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1097\/CJI.0b013e3181e475e9","article-title":"Cord blood natural killer cells exhibit impaired lytic immunological synapse formation that is reversed with IL-2 exvivo expansion","volume":"33","author":"Xing","year":"2010","journal-title":"J Immunother"},{"key":"10.1016\/j.exphem.2016.10.003_bib51","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1365-2141.2009.07768.x","article-title":"The phenotypic and functional characteristics of umbilical cord blood and peripheral blood natural killer cells","volume":"147","author":"Verneris","year":"2009","journal-title":"Br J Haematol"},{"key":"10.1016\/j.exphem.2016.10.003_bib52","doi-asserted-by":"crossref","first-page":"3901","DOI":"10.1158\/1078-0432.CCR-10-0735","article-title":"Cytotoxicity of activated natural killer cells against pediatric solid tumors","volume":"16","author":"Cho","year":"2010","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.exphem.2016.10.003_bib53","doi-asserted-by":"crossref","first-page":"4802","DOI":"10.1182\/blood-2012-08-449744","article-title":"IGHV-unmutated and IGHV-mutated chronic lymphocytic leukemia cells produce activation-induced deaminase protein with a full range of biologic functions","volume":"120","author":"Patten","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2016.10.003_bib54","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.bbmt.2007.10.014","article-title":"Immunotherapy for pediatric cancer","volume":"14","author":"Grupp","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.exphem.2016.10.003_bib55","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1182\/blood-2011-04-347070","article-title":"NK cell education after allogeneic transplantation: dissociation between recovery of cytokine-producing and cytotoxic functions","volume":"118","author":"Foley","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2016.10.003_bib56","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1146\/annurev.immunol.17.1.189","article-title":"Natural killer cells in antiviral defense: function and regulation by innate cytokines","volume":"17","author":"Biron","year":"1999","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.exphem.2016.10.003_bib57","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1038\/35074122","article-title":"IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity","volume":"410","author":"Shankaran","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2016.10.003_bib58","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/S1083-8791(00)70025-5","article-title":"Opposing roles of interferon-gamma on CD4+ T cell-mediated graft-versus-host disease: effects of conditioning","volume":"6","author":"Welniak","year":"2000","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X16306580?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X16306580?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,11]],"date-time":"2022-06-11T05:22:13Z","timestamp":1654924933000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X16306580"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":58,"alternative-id":["S0301472X16306580"],"URL":"https:\/\/doi.org\/10.1016\/j.exphem.2016.10.003","relation":{},"ISSN":["0301-472X"],"issn-type":[{"value":"0301-472X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetically re-engineered K562\u00a0cells significantly expand and functionally activate cord blood natural killer cells: Potential for adoptive cellular immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Experimental Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exphem.2016.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 ISEH - International Society for Experimental Hematology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}